









Markets
/
Stocks
/
nasdaq-rnaz
/

Transcode Therapeutics Inc

RNAZ

11.570USD

+0.070+0.61%

Market hours （ET）Quotes delayed by 15 min

9.64MMarket Cap

LossP/E TTM



Transcode Therapeutics Inc

11.570

+0.070+0.61%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

21.35%-3.10M

44.45%-3.15M

-11.60%-3.91M

46.72%-2.34M

12.77%-3.94M

-40.89%-5.66M

20.72%-3.51M

-30.23%-4.39M

-14.31%-4.51M

-151.11%-4.02M

-44.13%-4.42M

---3.37M

---3.95M

---1.60M

---3.07M

Net income from continuing operations

-263.27%-12.09M

-44.73%-5.92M

56.20%-2.32M

-19.56%-5.19M

30.94%-3.33M

20.38%-4.09M

-23.55%-5.30M

7.06%-4.34M

-38.81%-4.82M

-83.41%-5.13M

-84.13%-4.29M

---4.67M

---3.47M

---2.80M

---2.33M

Operating gains losses

-63.87%51.17K

-12.35%122.86K

-8.11%127.52K

3.81%142.83K

41.37%141.65K

375.08%140.17K

459.56%138.78K

506.18%137.59K

363.86%100.20K

1.78%29.50K

229.16%24.80K

--22.70K

--21.60K

--28.99K

--7.54K

Other non-cash items

----

450.10%596.96K

3.65%111.49K

3.62%110.48K

55.17%109.48K

561.03%108.52K

--107.56K

--106.62K

--70.56K

87.58%-23.54K

100.00%0.00

--0.00

---189.55K

---31.40K

Change in working capital

51.34%-455.12K

146.50%942.35K

-252.27%-1.92M

530.88%1.56M

-2205.20%-935.21K

-307.24%-2.03M

580.57%1.26M

-130.83%-363.12K

107.92%44.42K

-25.75%977.81K

66.30%-262.82K

--1.18M

---560.67K

--1.32M

---779.80K

-Change in prepaid expenses

215.09%129.47K

90.21%442.50K

-15.48%-692.90K

-45.25%768.48K

83.29%-112.50K

-3.35%232.64K

67.46%-600.02K

5.18%1.40M

-641.83%-673.21K

-69.84%240.71K

17.82%-1.84M

--1.33M

--124.25K

--798.07K

---2.24M

-Change in payables and accrued expense

71.01%-198.46K

127.62%576.68K

-158.37%-1.14M

152.10%908.30K

-218.84%-684.49K

-442.55%-2.09M

-3.69%1.96M

-1329.90%-1.74M

184.96%575.98K

17.45%609.45K

35.64%2.03M

---121.93K

---677.93K

--518.91K

--1.50M

-Change in other current assets

----

--0.00

---111.86K

----

-Change in other current liabilities

6.09%-25.41K

193.24%25.41K

100.00%0.00

-100.00%0.00

---27.06K

---27.25K

---27.44K

--81.75K

100.00%0.00

--0.00

----

--0.00

---6.99K

--0.00

---35.69K

Cash from non-recurring investing activities

Cash from operating activities

21.35%-3.10M

44.45%-3.15M

-11.60%-3.91M

46.72%-2.34M

12.77%-3.94M

-40.89%-5.66M

20.72%-3.51M

-30.23%-4.39M

-14.31%-4.51M

-151.11%-4.02M

-44.13%-4.42M

---3.37M

---3.95M

---1.60M

---3.07M

Investing cash flow

Net cash from continuing investing activities

----

--500.00

179.42%12.87K

-74.84%4.55K

-70.25%3.84K

-100.00%0.00

--4.61K

-56.94%18.11K

-57.93%12.90K

-65.89%28.21K

-100.00%0.00

--42.05K

--30.66K

--82.73K

--71.55K

Capital expenditures

----

--500.00

179.42%12.87K

-74.84%4.55K

-70.25%3.84K

-100.00%0.00

--4.61K

-56.94%18.11K

-57.93%12.90K

-67.09%28.21K

-100.00%0.00

--42.05K

--30.66K

--85.73K

--71.55K

Net cash flow from disposal of fixed assets

----

--500.00

179.42%12.87K

-74.84%4.55K

-70.25%3.84K

-100.00%0.00

--4.61K

-56.94%18.11K

-57.93%12.90K

-65.89%28.21K

-100.00%0.00

--42.05K

--30.66K

--82.73K

--71.55K

Cash from non-current investing activities

Net cash flow from investing activities

----

---500.00

-179.42%-12.87K

74.84%-4.55K

70.25%-3.84K

100.00%0.00

---4.61K

56.94%-18.11K

57.93%-12.90K

65.89%-28.21K

100.00%0.00

---42.05K

---30.66K

---82.73K

---71.55K

Financing cash flow

Cash flow from continuous financing activities

45.47%8.85M

624.02%7.08M

-66.89%2.45M

-87.65%785.20K

415.56%6.09M

333.16%978.15K

3372.94%7.39M

--6.36M

19614.24%1.18M

2280.78%225.82K

-100.88%-225.82K

--0.00

--5.99K

--9.48K

--25.56M

Net cash flow from debt Issuance/repayment

----

--0.00

Net cash flow from common stock issuance/repurchase

45.47%8.85M

624.02%7.08M

-66.27%2.45M

-87.91%785.20K

415.56%6.09M

--978.15K

--7.26M

--6.50M

--1.18M

-100.00%0.00

----

--9.48K

--26.34M

Proceeds from stock option exercised by employees

----

--0.00

-100.00%0.00

--0.00

--5.99K

----

Net cash flow from other financing activities

----

160.14%135.80K

---135.80K

----

--225.82K

70.87%-225.82K

----

--0.00

---775.28K

Net cash from non-recurrent financing activities

Net cash from financing activities

45.47%8.85M

624.02%7.08M

-66.89%2.45M

-87.65%785.20K

415.56%6.09M

333.16%978.15K

3372.94%7.39M

--6.36M

19614.24%1.18M

2280.78%225.82K

-100.88%-225.82K

--0.00

--5.99K

--9.48K

--25.56M

Net cash flow

Beginning cash balance

109.97%5.81M

-74.83%1.88M

-6.10%3.35M

202.82%4.91M

-44.30%2.77M

-15.22%7.45M

-73.42%3.57M

-90.37%1.62M

-76.14%4.97M

-60.93%8.79M

16789.40%13.44M

--16.85M

--20.83M

--22.50M

--79.57K

Current period cash flow changes

168.31%5.76M

183.99%3.94M

-138.11%-1.48M

-179.96%-1.56M

164.14%2.15M

-22.58%-4.69M

183.49%3.88M

157.11%1.95M

15.79%-3.35M

-128.32%-3.82M

-120.73%-4.65M

---3.41M

---3.97M

---1.67M

--22.42M

Ending cash balance

135.45%11.57M

109.97%5.81M

-74.83%1.88M

-6.10%3.35M

202.82%4.91M

-44.30%2.77M

-15.22%7.45M

-73.42%3.57M

-90.37%1.62M

-76.14%4.97M

-60.93%8.79M

--13.44M

--16.85M

--20.83M

--22.50M

Free cash flow

----

44.44%-3.15M

-11.82%-3.93M

46.84%-2.34M

12.93%-3.94M

-39.91%-5.66M

20.62%-3.51M

-29.16%-4.41M

-13.75%-4.53M

-140.02%-4.05M

-40.85%-4.42M

---3.41M

---3.98M

---1.69M

---3.14M

Currency unit

USD

Audit opinions

KeyAI

